Clicky

Agenus Inc.(AGEN) News

Date Title
Jun 25 Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag
Jun 24 FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer
Jun 17 Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology
Jun 16 Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock
Jun 16 SRPT Plummets on Second Patient Death After DMD Gene Therapy Infusion
Jun 10 Agenus Announces Virtual Annual Shareholders Meeting
Mar 25 Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025
Mar 25 Here's Why Agenus (AGEN) Is a Great 'Buy the Bottom' Stock Now
Mar 19 Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation
Mar 12 Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Moves Amid Financial Challenges
Mar 12 Q4 2024 Agenus Inc Earnings Call
Mar 11 Agenus (AGEN) Q4 2024 Earnings Call Transcript
Mar 11 Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates
Mar 11 Agenus: Q4 Earnings Snapshot
Mar 11 Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program
Feb 24 Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting
Feb 21 Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?
Feb 20 Travere Therapeutics (TVTX) Reports Q4 Loss, Tops Revenue Estimates
Feb 12 Agenus’ BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting
Nov 7 Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024